Hangzhou Haoyue Personal Care Co., Ltd (SHA:605009)
China · Delayed Price · Currency is CNY 31.27
-0.45 (-1.42%)
At close: Feb 6, 2026
SHA:605009 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 3,521 | 2,844 | 2,678 | 2,740 | 2,404 | 2,545 |
Other Revenue | 85.18 | 85.18 | 79.04 | 62.39 | 57.85 | 46.02 |
| 3,607 | 2,929 | 2,757 | 2,802 | 2,462 | 2,591 | |
Revenue Growth (YoY) | 32.43% | 6.25% | -1.62% | 13.82% | -4.98% | 32.64% |
Cost of Revenue | 2,513 | 2,120 | 2,023 | 2,158 | 1,818 | 1,699 |
Gross Profit | 1,093 | 809.33 | 733.98 | 644.28 | 644 | 892.41 |
Selling, General & Admin | 614.49 | 287.53 | 202.32 | 155.2 | 138.79 | 122.27 |
Research & Development | 129.8 | 107.2 | 104.8 | 101.38 | 91.15 | 86.27 |
Other Operating Expenses | -8.33 | -14.17 | -5.91 | 5.43 | -4.7 | 8.12 |
Operating Expenses | 740.2 | 386.18 | 292.04 | 263.53 | 235.39 | 216.31 |
Operating Income | 353.03 | 423.15 | 441.93 | 380.75 | 408.61 | 676.11 |
Interest Expense | -16.14 | -15.86 | -13.18 | -5.56 | -5.96 | -13.81 |
Interest & Investment Income | 16.98 | 47.02 | 65.48 | 66.05 | 64.31 | 18.29 |
Currency Exchange Gain (Loss) | 7.43 | 7.43 | 1.24 | 0.9 | -1.3 | -2.33 |
Other Non Operating Income (Expenses) | -14.38 | -12.89 | -1.41 | -0.29 | 12.2 | -2.97 |
EBT Excluding Unusual Items | 346.92 | 448.85 | 494.07 | 441.85 | 477.86 | 675.29 |
Gain (Loss) on Sale of Investments | - | - | - | - | -51.24 | - |
Gain (Loss) on Sale of Assets | 7.17 | 5.02 | 3.01 | 0.21 | -1.05 | 0.13 |
Asset Writedown | -10.46 | -0.63 | -4.19 | - | -9.63 | - |
Other Unusual Items | 16.8 | 7.53 | 15.01 | 14.31 | - | 26.16 |
Pretax Income | 360.42 | 460.77 | 507.9 | 456.37 | 415.94 | 701.58 |
Income Tax Expense | 64 | 73.26 | 69.3 | 33.49 | 53.28 | 99.62 |
Net Income | 296.42 | 387.51 | 438.6 | 422.88 | 362.67 | 601.96 |
Net Income to Common | 296.42 | 387.51 | 438.6 | 422.88 | 362.67 | 601.96 |
Net Income Growth | -29.91% | -11.65% | 3.72% | 16.60% | -39.75% | 90.90% |
Shares Outstanding (Basic) | 213 | 216 | 216 | 220 | 223 | 195 |
Shares Outstanding (Diluted) | 213 | 216 | 216 | 220 | 223 | 195 |
Shares Change (YoY) | -1.75% | -0.00% | -1.76% | -1.17% | 14.42% | 16.58% |
EPS (Basic) | 1.39 | 1.79 | 2.03 | 1.92 | 1.63 | 3.09 |
EPS (Diluted) | 1.39 | 1.79 | 2.03 | 1.92 | 1.63 | 3.09 |
EPS Growth | -28.65% | -11.63% | 5.58% | 17.98% | -47.34% | 63.75% |
Free Cash Flow | -160.07 | -63.83 | 502.4 | 190.07 | 356.9 | 353.06 |
Free Cash Flow Per Share | -0.75 | -0.29 | 2.32 | 0.86 | 1.60 | 1.81 |
Dividend Per Share | 0.607 | 1.214 | 1.214 | 0.536 | 0.714 | 0.479 |
Dividend Growth | -50.00% | - | 126.68% | -25.00% | 49.00% | - |
Gross Margin | 30.31% | 27.63% | 26.62% | 22.99% | 26.16% | 34.44% |
Operating Margin | 9.79% | 14.45% | 16.03% | 13.59% | 16.60% | 26.10% |
Profit Margin | 8.22% | 13.23% | 15.91% | 15.09% | 14.73% | 23.23% |
Free Cash Flow Margin | -4.44% | -2.18% | 18.22% | 6.78% | 14.50% | 13.63% |
EBITDA | 475.88 | 545.93 | 564.6 | 465.94 | 480.8 | 731.21 |
EBITDA Margin | 13.20% | 18.64% | 20.48% | 16.63% | 19.53% | 28.22% |
D&A For EBITDA | 122.85 | 122.78 | 122.67 | 85.19 | 72.19 | 55.1 |
EBIT | 353.03 | 423.15 | 441.93 | 380.75 | 408.61 | 676.11 |
EBIT Margin | 9.79% | 14.45% | 16.03% | 13.59% | 16.60% | 26.10% |
Effective Tax Rate | 17.76% | 15.90% | 13.64% | 7.34% | 12.81% | 14.20% |
Revenue as Reported | 3,607 | 2,929 | 2,757 | 2,802 | 2,462 | 2,591 |
Advertising Expenses | - | 149.93 | 83.35 | 48.56 | 38.72 | 19.33 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.